On march 12, the Indian government issued a notification banning the sale of 350 fixed dose combination drugs (FDC’s).
Pharmaceutical Company Pfizer Stops Selling Corex in India
The government of India vide notification dated March 10, 2016, has prohibited the manufacture for sale and distribution of cough syrup Corex with immediate effect.
The government of India vide notification dated March 10, 2016, has prohibited the manufacture for sale and distribution of cough syrup Corex with immediate effect.
‘GlaxoSmithKline has stopped sale of Crocin Cold & Flu, after the government announced a ban on sale of fixed dose combination drugs (FDCs).’
"While the product may still be available in stores, GSK has stopped invoicing it," an official aware of the developments said. On march 12, the government issued a notification banning 350 FDC’s and it has now extended the ban to common medicines such as Crocin Cold and Flu, D-Cold Total, Sumo, Gastrogyl, Chericof, Nasivion, Nimulid, Dolo, Decoff, O2 and Oflox.
Source-Medindia
US Food And Drug Administration Approves GSK's Drug For Severe Asthma
The drug, Nucala is administered once every four weeks by subcutaneous injection into the upper arm, thigh, or abdomen.
The drug, Nucala is administered once every four weeks by subcutaneous injection into the upper arm, thigh, or abdomen.
GSK Encounters Initial Resistance Following Directional Shift, Says GlobalData Analyst
GlaxoSmithKline plc (GSK) is realigning its operating structure with its corporate objectives and cashing in on its assets.
GlaxoSmithKline plc (GSK) is realigning its operating structure with its corporate objectives and cashing in on its assets.
Comic Relief and GSK Collaborates to Reduce Global Malarial Rates By 2030
Comic relief and GSK has contributed £5m and £17m respectively for reducing malaria in five endemic countries in Sub-Saharan Africa and Asia.
Comic relief and GSK has contributed £5m and £17m respectively for reducing malaria in five endemic countries in Sub-Saharan Africa and Asia.
